Related references
Note: Only part of the references are listed.Biophysical characterization of recombinant HIV-1 subtype C virus infectivity factor
Daniela Gallerano et al.
AMINO ACIDS (2011)
On the Solution Conformation and Dynamics of the HIV-1 Viral Infectivity Factor
Sean R. Marcsisin et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif
Serena Bernacchi et al.
NUCLEIC ACIDS RESEARCH (2011)
Molecular Insight into the Conformational Dynamics of the Elongin BC Complex and Its Interaction with HIV-1 Vif
Sean R. Marcsisin et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Dissection of the HIV Vif Interaction with Human E3 Ubiquitin Ligase
Leslie S. Wolfe et al.
JOURNAL OF VIROLOGY (2010)
Structural Disorder in the HIV-1 Vif Protein and Interaction-Dependent Gain of Structure
Tali H. Reingewertz et al.
PROTEIN AND PEPTIDE LETTERS (2010)
The SOCS-Box of HIV-1 Vif Interacts with ElonginBC by Induced-Folding to Recruit Its Cul5-Containing Ubiquitin Ligase Complex
Julien R. C. Bergeron et al.
PLOS PATHOGENS (2010)
Molecular Structure and Biochemical Properties of the HCCH-Zn2+ Site in HIV-1 Vif
Kalyan Giri et al.
BIOCHEMISTRY (2009)
Conformational Analysis of a Peptide Approximating the HCCH Motif in HIV-1 Vif
Kalyan Giri et al.
BIOPOLYMERS (2009)
The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state
Tali H. Reingewertz et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements
Ya-Lin Chiu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
HIV-1 accessory proteins - Ensuring viral survival in a hostile environment
Michael H. Malim et al.
CELL HOST & MICROBE (2008)
Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases
Wenyan Zhang et al.
CELLULAR MICROBIOLOGY (2008)
Advances in the structural understanding of Vif proteins
Pierre Barraud et al.
CURRENT HIV RESEARCH (2008)
Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction
Zhiwen He et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly
Bradford J. Stanley et al.
JOURNAL OF VIROLOGY (2008)
Distinct Determinants in HIV-1 Vif and Human APOBEC3 Proteins Are Required for the Suppression of Diverse Host Anti-Viral Proteins
Wenyan Zhang et al.
PLOS ONE (2008)
HIV-I Vif, APOBEC, and intrinsic immunity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2008)
HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes
Ritu Golla-Gaur et al.
VIROLOGY (2008)
7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G
Tao Wang et al.
JOURNAL OF VIROLOGY (2007)
Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 vif and inhibitors of Vif-APOBEC3G binding
Andrew Mehle et al.
JOURNAL OF VIROLOGY (2007)
The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G
James H. Miller et al.
RETROVIROLOGY (2007)
Mass spectrometry analysisof HIVA Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity
Jared R. Auclair et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Characterization of a novel cullin5 binding domain in HIV-1 vif
Zuoxiang Xiao et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
RNA and DNA binding properties of HIV-1 vif protein - A fluorescence study
Serena Bernacchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F
Yiliang Yang et al.
VIROLOGY (2007)
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F
Rebecca A. Russell et al.
JOURNAL OF VIROLOGY (2007)
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2007)
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation
Kun Luo et al.
JOURNAL OF VIROLOGY (2007)
Adenovirus E4orF6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53
Kun Luo et al.
FASEB JOURNAL (2007)
APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC linker
Atuhani Burnett et al.
JOURNAL OF VIROLOGY (2007)
Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA
Bin Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of tRNALys3-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationv
Fei Guo et al.
JOURNAL OF VIROLOGY (2006)
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination
Kate N. Bishop et al.
JOURNAL OF VIROLOGY (2006)
A zinc-binding region in vif binds cul5 and determines cullin selection
Andrew Mehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif
Zuoxiang Xiao et al.
VIROLOGY (2006)
Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G
Barbel Schrofelbauer et al.
JOURNAL OF VIROLOGY (2006)
Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F
CJ Tian et al.
JOURNAL OF VIROLOGY (2006)
Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors
BR Cullen
JOURNAL OF VIROLOGY (2006)
Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G
SM Kaiser et al.
JOURNAL OF VIROLOGY (2006)
Natural variation in Vif: Differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification
Viviana Simon et al.
PLOS PATHOGENS (2005)
Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases
B Schröfelbauer et al.
JOURNAL OF VIROLOGY (2005)
Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEOG
K Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase
BD Liu et al.
JOURNAL OF VIROLOGY (2005)
Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes
MA Khan et al.
JOURNAL OF VIROLOGY (2005)
Complementary function of the two catalytic domains of APOBEC3G
F Navarro et al.
VIROLOGY (2005)
Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli -: art. no. 1
HP Sorensen et al.
MICROBIAL CELL FACTORIES (2005)
APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase
R Suspène et al.
NUCLEIC ACIDS RESEARCH (2004)
Influence of primate lentiviral vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G
BD Liu et al.
JOURNAL OF VIROLOGY (2004)
HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles
M Douaisi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 Virions through interactions with viral and nonviral RNAs
ES Svarovskaia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein
TM Alce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The interaction between HIV-1 Gag and APOBEC3G
S Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines
YK Yu et al.
GENES & DEVELOPMENT (2004)
Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation
A Mehle et al.
GENES & DEVELOPMENT (2004)
APOBEC3G incorporation into human immunodeficiency virus type 1 particles
W Zennou et al.
JOURNAL OF VIROLOGY (2004)
Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
K Luo et al.
JOURNAL OF VIROLOGY (2004)
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor
A Schäfer et al.
VIROLOGY (2004)
Core-binding factors in hematopoiesis and immune function
MFTR de Bruijn et al.
ONCOGENE (2004)
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Q Yu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G
SG Conticello et al.
CURRENT BIOLOGY (2003)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
K Stopak et al.
MOLECULAR CELL (2003)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins
B Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
M Marin et al.
NATURE MEDICINE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Human immunodeficiency virus type I Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA
MA Khan et al.
JOURNAL OF VIROLOGY (2001)
The leukemia-associated AML1 (Runx1)-CBFβ complex functions as a DNA-induced molecular clamp
J Bravo et al.
NATURE STRUCTURAL BIOLOGY (2001)
The multimerization of human immunodeficiency virus type I Vif protein - A requirement for Vif function in the viral life cycle
SC Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Association of human immunodeficiency virus type 1 vif with RNA and its role in reverse transcription
M Dettenhofer et al.
JOURNAL OF VIROLOGY (2000)
Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process
H Zhang et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
